Ona Therapeutics to develop ADC with WuXi’s payload-linker platform

Ona Therapeutics develops ADCs for treatment-resistant cancers using a discovery platform. Credit: Gorodenkoff / Shutterstock.com.



  • WuXi XDC Cayman